Tribun Health secures €15 Million in series B funding

Create PDF

Sept. 6, 2023—Paris-based Tribun Health announced the completion of its series B funding, securing an investment of €15 million. This financing round is led by Fonds Patient Autonome, managed by Bpifrance, and LBO France, along with new investors, including Owkin and Vivalto, with whom the company has also signed commercial agreements. Tribun says the capital will be used to accelerate the development and commercialization of its AI-powered digital pathology portfolio, facilitate the expansion of sales and marketing activities in Europe and North America, and serve as funding for its recent purchase of Keen Eye.